NDC11 54092047101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 54092-0471-01 | 54092-0471 |
| 54092-0471-1 | 54092-0471 |
| 54092-471-01 | 54092-471 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MYDAYIS | DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, AND AMPHETAMINE SULFATE | Takeda Pharmaceuticals America, Inc. | 141a7970-3f06-44ea-9ab7-aeece2c085fc | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 54092-471-01 54092-471 54092047101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.